We are live on ! Find out more
IP

Invenire Partners Portfolio holdings

AUM $65.4M
1-Year Est. Return 18.1%
This Fund
S&P 500
This Quarter Est. Return
+3.15%
1 Year Est. Return
-18.1%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$65.4M
AUM Growth
-$9.91M
Cap. Flow
-$2.45M
Cap. Flow %
-3.75%
Top 10 Hldgs %
57.26%
Holding
36
New
7
Increased
10
Reduced
3
Closed
10

Sector Composition

1 Healthcare 34.72%
2 Technology 26.01%
3 Industrials 21.81%
4 Communication Services 9.23%
5 Consumer Discretionary 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLAR icon
26
CALL
Clarus
CLAR
$131M
$3.5K 0.01%
+700
New +$13.6K
ASPN icon
27
Aspen Aerogels
ASPN
$419M
-24,494
Closed -$242K
CMCO icon
28
Columbus McKinnon
CMCO
$426M
-68,597
Closed -$1.95M
CYRX icon
29
CryoPort
CYRX
$831M
-45,283
Closed -$1.4M
MX icon
30
Magnachip Semiconductor
MX
$128M
-115,000
Closed -$1.67M
NDLS icon
31
Noodles & Co
NDLS
$67.8M
-23,994
Closed -$902K
NOA
32
North American Construction
NOA
$359M
-308,270
Closed -$3.38M
SHYF
33
DELISTED
The Shyft Group
SHYF
-103,100
Closed -$1.92M
UIS icon
34
Unisys
UIS
$277M
-268,000
Closed -$3.22M
DLA
35
DELISTED
Delta Apparel Inc.
DLA
-96,358
Closed -$2.73M

Similar funds

Invenire Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Invenire Partners held 36 positions worth $65.4M, down 13% from $75.3M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Invenire Partners withdrew a net $2.45M in Q3 2022, closing 10 positions and reducing 3 holdings. Its most notable exit was North American Construction, an estimated $3.38M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.

Against the trend, Invenire Partners opened a new position in Edgio, Inc. Common Stock worth $2.92M.

  • Invenire Partners's largest Q3 2022 buy was Edgio, Inc. Common Stock: 26,250 shares worth $2.92M.
  • Invenire Partners added most to Apyx Medical in Q3 2022, an estimated $2.63M increase.
  • Invenire Partners's biggest Q3 2022 reduction was Arena Group, cutting an estimated $1.61M.
  • Invenire Partners fully exited North American Construction in Q3 2022, selling an estimated $3.38M.
  • Invenire Partners's ten largest holdings make up 57% of its $65.4M portfolio in Q3 2022.
  • Invenire Partners opened 7 new positions and closed 10 in Q3 2022.
  • Invenire Partners's portfolio value fell 13% quarter-over-quarter to $65.4M.

Based on Invenire Partners's 13F filing for Q3 2022, filed 14 Nov 2022.